(Q45887190)

17 December 2017

title

Generating p53-specific cytotoxic T lymphocytes by recombinant adenoviral vector-based vaccination in mice, but not man. (English)

1 reference

17 December 2017

0 references

1 reference

Kuball J

1

1 reference

17 December 2017

Schuler M

2

1 reference

17 December 2017

Antunes Ferreira E

3

1 reference

17 December 2017

Herr W

4

1 reference

17 December 2017

Neumann M

5

1 reference

17 December 2017

Obenauer-Kutner L

6

1 reference

17 December 2017

Westreich L

7

1 reference

17 December 2017

Huber C

8

1 reference

17 December 2017

Wölfel T

9

1 reference

17 December 2017

Theobald M

10

1 reference

17 December 2017

publication date

1 July 2002

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

9

1 reference

17 December 2017

issue

13

1 reference

17 December 2017

page(s)

833-843

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301709

exact match

0 references

cites work

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

Targeting p53 as a general tumor antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

p53 as a target for cancer vaccines: recombinant canarypox virus vectors expressing p53 protect mice against lethal tumor cell challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

The use of transgenic mice to generate high affinity p53 specific cytolytic T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

Low avidity recognition of self-antigen by T cells permits escape from central tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

High sensitivity, low affinity--paradox of T-cell receptor recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

Longitudinal follow-up of cellular and humoral immunity induced by recombinant adenovirus-mediated gene therapy in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

Help for cytotoxic-T-cell responses is mediated by CD40 signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

Generation of T cells specific for the wild-type sequence p53(264-272) peptide in cancer patients: implications for immunoselection of epitope loss variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

An optimal viral peptide recognized by CD8+ T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

Gain of function mutations in p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

The Ability of Variant Peptides to Reverse the Nonresponsiveness of T Lymphocytes to the Wild-Type Sequence p53264-272 Epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

Dendritic cells transduced with wild-type p53 gene elicit potent anti-tumour immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

7 January 2021

Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

7 January 2021

Characterization of human proliferative T cell responses to adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

7 January 2021

Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

7 January 2021

Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

7 January 2021

Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

7 January 2021

Transporter (TAP)- and proteasome-independent presentation of a melanoma-associated tyrosinase epitope

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301709

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301709

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017